The last month has been better than spectacular for the penny stock of ScripsAmerica, Inc. (SCRC). Closing green 16 of the last 17 trading sessions, saying that SCRC stock is on a bullish run is a bit of an understatement. Each of the last 5 sessions have all been new 52 week highs as the one year anniversary. Although the supplier of prescription, OTC and nutraceutical drugs missed the cut for the top 10 penny stocks traded on Wednesday, perhaps Awesome Penny Stocks could soon call onto Money Runners to try to quickly find a solution to help Xumanii (XUII) hit $1 so they don’t need to keep their promise of retiring.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
Top 10 Penny Stocks Traded Wednesday, July 10
| Symbol | Price | % Change | $ Volume | Share Volume | Trades |
|---|---|---|---|---|---|
| FNMA | 1.53 | -5.56% | 44,466,985 | 28,979,817 | 4,891 |
| ONVO | 5.40 | +9.76% | 19,497,334 | 3,810,661 | 3,164 |
| AAMRQ | 4.72 | 0.00% | 25,513,751 | 5,251,663 | 2,314 |
| FMCC | 1.44 | -6.49% | 13,369,191 | 9,256,839 | 2,137 |
| XUII | 0.308 | -18.52% | 4,865,222 | 14,907,993 | 2,080 |
| NTEK | 0.083 | -21.70% | 1,722,033 | 20,573,843 | 974 |
| ARTH | 1.27 | -2.31% | 2,306,634 | 1,805,216 | 719 |
| KVPHQ | 0.72 | +14.29% | 2,051,245 | 2,793,102 | 707 |
| SGLB | 0.0749 | -9.76% | 1,093,082 | 13,663,208 | 695 |
| GNBT | 0.0415 | +8.36% | 841,822 | 20,117,842 | 671 |
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
No new news has surfaced from ScripsAmerica since their announcement on June 26, detailing the representation agreement the Company entered into with DPG Distribution for the exclusive right to purchase, promote and resell its RapiMed OTC products throughout North America, commencing with its children’s pain reliever and fever reducer. However, since that date, SCRC stock has gained 100% and is embarking on the $1 mark for the first time in its 1 year trading history.
In reverse to the trend of SCRC, Awesome Penny Stocks promise of XUII stock breaking $1 or they would retire from pumping penny stocks had a monkey wrench thrown into its spokes Wednesday. Share prices tumbled as if it was the poster stock for Jenga to as low as 0.2721, a better than -0.10 drop from the open price.
To try to boost investor confidence, APS and their affiliates claimed in their after-market alerts that the “temporary retraction will be short-lived and that we will see brand new highs as early as this week or by Monday at the latest.” The group also stated that they “have reason to believe that certain companies such as Google, Yahoo and Microsoft may consider the potential buy out of XUII and its assets (xumanii dot com).”
Let’s just say that XUII stock will never see $1, not even return to 0.40.
On a side note, we reported yesterday how NYSE Amex listed Inovio Pharmaceuticals, Inc. (INO) exploded to new highs. Well, Avtar S. Dhillon, a director for Inovio and co-founder of both Arch Therapeutics, Inc. (ARTH) and OncoSec Medical Inc. (ONCS) had a better day than we expected as ARTH stock and ONCS stock ended the Wednesday trading session as the 10th and 13th, respectively, most traded OTC listed stocks. Traders who jumped on the ARTH stock bandwagon at 0.79 are crushing it right now.
About SCRC Stock
ScripsAmerica, Inc. is a healthcare services company focused on efficient supply chain management, from strategic sourcing to delivering niche generic pharmaceuticals to market.
Click here to view the SEC filings for SCRC.
Click here to view the website for ScripsAmerica.
Last 5 Trading Sessions:
| Date | Last | Change | % Change | Volume |
| 07/10/13 | 0.9000 | +0.1525 | +20.40% | 622,700 |
| 07/09/13 | 0.7475 | +0.0675 | +9.93% | 598,900 |
| 07/08/13 | 0.6800 | +0.0900 | +15.25% | 702,700 |
| 07/05/13 | 0.5900 | +0.0600 | +11.32% | 326,500 |
| 07/03/13 | 0.5300 | +0.0050 | +0.95% | 546,100 |
Stay Connected With Us:
Bottom Line:
Watch for SCRC to break past $1 and land on the top 10 penny stocks traded list before the end of the week. The PPS run can simply be explained as traders beating the market makers at their own game and forcing them to continually cover short positions. Who could script a better revenge play against the MM’s for every time you got your bid whacked on a position you held.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)
ShareJUL
